JP2012515165A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012515165A5 JP2012515165A5 JP2011545498A JP2011545498A JP2012515165A5 JP 2012515165 A5 JP2012515165 A5 JP 2012515165A5 JP 2011545498 A JP2011545498 A JP 2011545498A JP 2011545498 A JP2011545498 A JP 2011545498A JP 2012515165 A5 JP2012515165 A5 JP 2012515165A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- composition according
- mammalian
- ranges
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14413409P | 2009-01-12 | 2009-01-12 | |
| US61/144,134 | 2009-01-12 | ||
| PCT/US2010/020673 WO2010081112A1 (en) | 2009-01-12 | 2010-01-11 | Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012515165A JP2012515165A (ja) | 2012-07-05 |
| JP2012515165A5 true JP2012515165A5 (https=) | 2013-02-28 |
| JP5981141B2 JP5981141B2 (ja) | 2016-08-31 |
Family
ID=42316862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011545498A Expired - Fee Related JP5981141B2 (ja) | 2009-01-12 | 2010-01-11 | 多臓器不全症候群（ｍｏｄｓ）の予防および／または処置のためのインターロイキン−２２の使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8956605B2 (https=) |
| EP (1) | EP2385841B1 (https=) |
| JP (1) | JP5981141B2 (https=) |
| CN (1) | CN102348463B (https=) |
| AU (1) | AU2010203446B2 (https=) |
| CA (1) | CA2748392C (https=) |
| WO (1) | WO2010081112A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| WO2014145016A2 (en) | 2013-03-15 | 2014-09-18 | Genentech, Inc. | Il-22 polypeptides and il-22 fc fusion proteins and methods of use |
| CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
| US11510966B2 (en) | 2016-04-15 | 2022-11-29 | Evive Biotechnology (Shanghai) Ltd | Use of IL-22 in treating necrotizing enterocolitis |
| EP4106794A4 (en) | 2020-02-19 | 2024-03-20 | Evive Biotechnology (Shanghai) Ltd | METHOD FOR TREATING TRANSPLANT AND HOST DISEASE |
| CN112007146A (zh) * | 2020-09-03 | 2020-12-01 | 上海市儿童医院 | Il-22在治疗和/或预防脓毒症诱发的肝脏损伤的药物中的用途 |
| US20240033232A1 (en) * | 2021-03-10 | 2024-02-01 | Wen Tan | New use of (R)-B2-agonists in treatment of sepsis and acute respiratory distress syndrome |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010023070A1 (en) * | 1998-05-29 | 2001-09-20 | Reinhard Ebner | Interleukins-21 and 22 |
| EP1082433A4 (en) | 1998-05-29 | 2003-01-02 | Human Genome Sciences Inc | Interleukins 21 and 22 |
| US7226591B2 (en) * | 2000-05-22 | 2007-06-05 | Genentech, Inc. | Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| US20050148029A1 (en) * | 2003-09-29 | 2005-07-07 | Biosite, Inc. | Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes |
| CN101219208B (zh) * | 2005-01-04 | 2010-08-11 | 健能隆医药技术（上海）有限公司 | 白介素-22的医药用途 |
| CN100515491C (zh) * | 2005-01-04 | 2009-07-22 | 健能隆医药技术（上海）有限公司 | 白介素-22的医药用途 |
| WO2007149814A1 (en) * | 2006-06-19 | 2007-12-27 | Wyeth | Methods of modulating il-22 and il-17 |
| WO2008085229A2 (en) * | 2006-11-15 | 2008-07-17 | Arteriocyte Inc. | Cell-based therapies for treating liver disease |
| CN101168049A (zh) * | 2007-10-23 | 2008-04-30 | 中国人民解放军军事医学科学院基础医学研究所 | 白介素-22在制备治疗肝病药物中的应用及其制备方法 |
-
2010
- 2010-01-11 WO PCT/US2010/020673 patent/WO2010081112A1/en not_active Ceased
- 2010-01-11 CN CN201080010768.7A patent/CN102348463B/zh active Active
- 2010-01-11 JP JP2011545498A patent/JP5981141B2/ja not_active Expired - Fee Related
- 2010-01-11 US US13/142,423 patent/US8956605B2/en active Active
- 2010-01-11 CA CA2748392A patent/CA2748392C/en active Active
- 2010-01-11 EP EP10729641.0A patent/EP2385841B1/en active Active
- 2010-01-11 AU AU2010203446A patent/AU2010203446B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012515165A5 (https=) | ||
| Li et al. | Role of interleukin-17 in acute pancreatitis | |
| Gao et al. | The potential role of IL-33/ST2 signaling in fibrotic diseases | |
| JP2017081972A5 (https=) | ||
| NO20082434L (no) | Materialer og fremgangsmater for behandling av kroniske fibrotiske sykdommer | |
| JP2007262090A5 (https=) | ||
| JP2011511805A5 (https=) | ||
| JP2013503110A5 (https=) | ||
| WO2010107177A3 (ko) | 캠펜을 유효성분으로 포함하는 비만, 이상지방혈증, 지방간 또는 인슐린 저항성 증후군의 예방 또는 치료용 조성물 | |
| WO2011156453A3 (en) | Therapeutic peptides | |
| SG151299A1 (en) | Gossypol co-crystals and the use thereof | |
| JP2015513535A5 (https=) | ||
| JP2007532685A5 (https=) | ||
| DK2089032T3 (da) | Farmaceutisk præparat der har antipsykotisk, antidepressiv eller antiepileptisk aktivitet med reducerede bivirkninger | |
| JP2007119497A5 (https=) | ||
| WO2006100679A3 (en) | Recombinant antibodies against human type ii transglutaminase and uses thereof | |
| JP2020502134A5 (https=) | ||
| JP2014532758A5 (https=) | ||
| WO2007121545A8 (en) | S-nitrosothiols containing compositions for the treatment of fatty liver diseases, obesity and other diseases associated with the metabolic syndrome and the use of such compositions | |
| JP2011012060A5 (https=) | ||
| Bersie et al. | Heterogeneity of lung phagocytes and clearance of apoptotic cells in lung injury and repair | |
| JP2013507383A5 (https=) | ||
| JP2009520696A5 (https=) | ||
| Feola et al. | Macrophage Phenotype Is Controlled by Inhibition of the NF-κB Signaling Pathway. | |
| Watanabe et al. | Regulation of GROα production in human bronchial epithelial cells |